Solutions

Clinical solutions

Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions

Consulting & Commercial

Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data

Case studies
Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

Technologies
Technology solutions from early phase through to post-marketing.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

From bottlenecks to breakthroughs
Human-centred strategies for faster study starts

More than monitoring
How modern monitoring paradigms impact CRA roles

Meeting requirements for Joint Clinical Assessments
A planning guide for health technology developers
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

Best practices in global flow cytometry quality control and harmonisation
5 March 2026. Register today.

When patients lead: Breaking barriers in ultra-rare disease drug development
3 March 2026. Register today.
About ICON

About ICON

Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality

ICON for

Patients Volunteers Investigators Jobs & Careers Investors Suppliers

Sustainability, charity, inclusion and belonging
ICON Cares is our commitment to making a positive impact on our people, environment and our community.

ICON at a glance
Delivering successful outcomes across the clinical development lifecycle.

Careers
Investors
Contact
日本語
简体中文

Home
News & Events
Social media

Social media

Showing 97 - 108 of 955 results for "*"

We’re proud to announce the expansion of oncology research within ICON’s Accellacare Site Network through the Brian Moran Cancer Institute at Duly Health and Care in Illinois. This strategic expansion strengthens our ab...

27 Jan

ICON Plc

ICON is proud to be recognised among the top global companies in the world for female employees. This recognition is based on a comprehensive survey of approximately 120,000 women across more than 36 countries, highlight...

27 Jan

ICON Plc

ICON is proud to be recognised among the top global companies in the world for female employees. As of 31 December 2024, women make up 70% of our workforce and hold 60% of director-level and above roles—a powerful refle...

27 Jan

ICON Plc

Join us at #OCTWestCoast on 11 February at 9am, for a special featured presentation by ICON’s Travis Caudill. Discover if AI is enough and why smarter site identifications still need human-centred strategies. This sessi...

27 Jan

ICON Plc

When exploring roles at a global organisation, you may come across terms like applicant tracking systems, often referred to as ATS. As part of our hiring clarity series, we’ve shared a short resource that explains what ...

Careers in finance look different when you are close to the centre of a global organisation. At ICON’s Dublin headquarters, our finance professionals gain exposure across regions, work closely with senior leaders, and a...

26 Jan

ICON Plc

Is AI enough? Artificial intelligence has revolutionised site identification, but it’s not the whole story. At SCOPE 2026, join Travis Caudill, VP – Feasibility, Site Selection & Medical Informatics, as he explores why s...

26 Jan

ICON Plc

Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, s...

26 Jan

ICON Plc

Collecting data through clinical trial tokenisation enables a longitudinal view of patient health, with insights from before and after a clinical trial. This can help to identify factors that may influence the effectiv...

26 Jan